Twin Tree Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,074
| Closed | -$1.91M | – | 457 |
|
|
2025
Q1 | $1.91M | Buy |
+7,074
| New | +$1.91M | ﹤0.01% | 320 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 499 |
|
|
2024
Q3 | – | Sell |
-43,749
| Closed | -$10.6M | – | 526 |
|
|
2024
Q2 | $10.6M | Buy |
43,749
+28,239
| +182% | +$6.86M | 0.02% | 109 |
|
|
2024
Q1 | $2.32M | Buy |
+15,510
| New | +$2.32M | 0.01% | 258 |
|
|
2023
Q4 | – | Sell |
-6,289
| Closed | -$1.11M | – | 476 |
|
|
2023
Q3 | $1.11M | Buy |
+6,289
| New | +$1.11M | ﹤0.01% | 289 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 477 |
|
|
2022
Q4 | – | Sell |
-72,861
| Closed | -$14.6M | – | 415 |
|
|
2022
Q3 | $14.6M | Buy |
72,861
+63,421
| +672% | +$12.7M | 0.03% | 76 |
|
|
2022
Q2 | $1.38M | Sell |
9,440
-22,344
| -70% | -$3.26M | ﹤0.01% | 383 |
|
|
2022
Q1 | $5.19M | Buy |
+31,784
| New | +$5.19M | 0.01% | 264 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 606 |
|
|
2021
Q3 | – | Sell |
-16,500
| Closed | -$2.8M | – | 649 |
|
|
2021
Q2 | $2.8M | Buy |
+16,500
| New | +$2.8M | 0.01% | 276 |
|
|
2020
Q4 | – | Sell |
-134
| Closed | -$20K | – | 508 |
|
|
2020
Q3 | $20K | Buy |
134
+117
| +688% | +$17.5K | ﹤0.01% | 448 |
|
|
2020
Q2 | $3K | Buy |
+17
| New | +$3K | ﹤0.01% | 551 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 531 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 524 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 581 |
|
|
2019
Q1 | – | Sell |
-5,919
| Closed | -$432K | – | 610 |
|
|
2018
Q4 | $432K | Sell |
5,919
-18,788
| -76% | -$1.37M | ﹤0.01% | 313 |
|
|
2018
Q3 | $2.16M | Buy |
24,707
+16,180
| +190% | +$1.42M | 0.01% | 160 |
|
|
2018
Q2 | $840K | Buy |
+8,527
| New | +$840K | 0.01% | 311 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 444 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 352 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 340 |
|